Award
Delivery Order #SPE2DR26FMER4
Delivery Order for ONCASPAR 5ml Vials Under Pharmaceutical Procurement Contract
Buyer
Defense Logistics Agency
Award Amount
$40,999.06
Ceiling
$40,999.06
Awarded
March 23, 2026
Period of Performance
Mar 23, 2026 – Apr 13, 2026
Identifier
SPE2DR26FMER4
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and healthcare solutions. The order concerns the procurement of ONCASPAR, specifically 3,750 units of 5 ml vials. This delivery falls under a larger, indefinite delivery vehicle pharmaceutical procurement contract managed by DMS Pharmaceutical Group, which aims to provide a reliable source for essential medications to government healthcare programs. The contract's significance lies in ensuring timely access to critical medications necessary for patient care within public sector health services. The scope of work for this delivery order includes the timely provision and distribution of these pharmaceutical units to support ongoing treatment needs. While specific competitive bid details are not noted, this delivery order is part of an ongoing multi-year agreement designed to streamline medication supply chains. The performance period for this order is short-term within the broader long-term contract, emphasizing prompt delivery to meet immediate government healthcare demands.
Description
4573366747!ONCASPAR 3,750 UNIT/5 ML VIAL 5ML